Hyponatremia in Cirrhosis: Role of Vasopressors

Affiliations

¹ Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
² Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India .

Comment

Shivani Chandel et al. Am J Gastroenterol. 2021.

. 2021 Jul 1;116(7):1561.

doi: 10.14309/ajg.0000000000001177.

¹ Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
² Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India .

No abstract available

Comment on

Hyponatremia in Cirrhosis: An Update.
Alukal JJ, John S, Thuluvath PJ. Alukal JJ, et al. Am J Gastroenterol. 2020 Nov;115(11):1775-1785. doi: 10.14309/ajg.0000000000000786. Am J Gastroenterol. 2020. PMID: 33156095 Review.

1. Alukal JJ, John S, Thuluvath PJ. Hyponatremia in cirrhosis: An update. Am J Gastroenterol 2020;115(11):1775–85.
1. Schrier RW, Arroyo V, Bernardi M, et al. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151–7.
1. Patel S, Nguyen DS, Rastogi A, et al. Treatment of cirrhosis-associated hyponatremia with midodrine and octreotide. Front Med (Lausanne) 2017;4:17.
1. Solà E, Solé C, Simón-Talero M, et al. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation: A randomized placebo-controlled trial. J Hepatol 2018;69(6):1250–9.